back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-04 21:48 Tx date 2024-04-01 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-11,533.33
-2,491 vol $4.63 each |
21,219 | |
| Filed 2024-03-28 20:22 Tx date 2024-03-28 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-12,243
-2,650 vol $4.62 each |
23,710 | |
| Filed 2024-03-28 20:21 Tx date 2024-03-27 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-12,269.50
-2,650 vol $4.63 each |
26,360 | |
| Filed 2024-03-28 20:20 Tx date 2024-03-26 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-12,296
-2,650 vol $4.64 each |
29,010 | |
| Filed 2024-03-28 20:19 Tx date 2024-03-25 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-12,693.50
-2,650 vol $4.79 each |
31,660 | |
| Filed 2024-03-22 17:49 Tx date 2024-03-21 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$181,971
+26,183 vol $6.95 each |
34,310 | |
| Filed 2024-03-22 17:44 Tx date 2024-03-19 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
57 - Exercise of rights
|
-26,183 vol |
92,367 | |
| Filed 2024-03-04 19:27 Tx date 2024-02-15 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,820
+2,000 vol $5.91 each |
8,127 | |
| Filed 2024-03-04 09:13 Tx date 2024-03-01 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,647,150
+237,000 vol $6.95 each |
2,403,376 | |
| Filed 2024-03-04 09:10 Tx date 2024-03-01 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+40,000 vol |
118,550 | |
| Filed 2023-12-27 17:31 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
6,127 | |
| Filed 2022-12-21 22:09 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
||
| Filed 2022-02-28 20:35 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
||
| Filed 2023-02-02 18:11 Tx date 2023-01-30 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+78,550 vol |
78,550 | |
| Filed 2023-02-02 18:10 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-02-02 18:09 Tx date 2023-01-30 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,274,964
+344,200 vol $12.42 each |
2,166,376 | |
| Filed 2023-02-02 17:55 Tx date 2023-01-30 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,274,964
+344,200 vol $12.42 each |
||
| Filed 2023-02-02 17:53 Tx date 2023-01-30 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,274,964
+344,200 vol $12.42 each |
||
| Filed 2022-12-21 22:09 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
6,127 | |
| Filed 2022-02-28 20:35 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
||
| Filed 2022-02-28 20:35 Tx date 2022-02-15 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,265
+729 vol $12.71 each |
6,127 | |
| Filed 2022-01-24 12:08 Tx date 2022-01-21 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,689,000
+300,000 vol $15.63 each |
1,822,176 | |
| Filed 2022-01-20 19:28 Tx date 2022-01-18 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,689,000
+300,000 vol $15.63 each |
||
| Filed 2022-01-20 19:28 Tx date 2022-01-18 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,689,000
+300,000 vol $15.63 each |
1,822,176 | |
| Filed 2021-10-06 11:09 Tx date 2021-08-13 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,327
+398 vol $28.46 each |
5,398 | |
| Filed 2021-06-29 14:42 Tx date 2021-06-28 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-53,970
-1,542 vol $35.00 each |
94,466 | |
| Filed 2021-06-09 17:36 Tx date 2021-06-09 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-55,160
-1,576 vol $35.00 each |
96,008 | |
| Filed 2021-06-04 17:14 Tx date 2021-06-04 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-908,054.0184
-29,352 vol $30.94 each |
97,584 | |
| Filed 2021-06-04 14:08 Tx date 2021-06-04 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-156,254.50
-5,000 vol $31.25 each |
5,000 | |
| Filed 2021-06-04 14:06 Tx date 2021-06-04 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$8,185
+5,000 vol $1.64 each |
10,000 | |
| Filed 2021-06-04 14:06 Tx date 2021-06-04 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-8,185
-5,000 vol $1.64 each |
1,522,176 | |
| Filed 2021-06-04 14:01 Tx date 2021-06-03 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-211,034.112
-6,648 vol $31.74 each |
126,936 | |
| Filed 2021-05-21 09:38 Tx date 2021-05-20 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-132,065.362
-3,770 vol $35.03 each |
133,584 | |
| Filed 2021-05-20 11:42 Tx date 2021-05-19 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-133,223.06
-3,800 vol $35.06 each |
137,354 | |
| Filed 2021-05-20 11:32 Tx date 2021-05-18 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-63,000
-1,800 vol $35.00 each |
141,154 | |
| Filed 2021-04-16 13:20 Tx date 2021-04-15 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-192,950.316
-5,512 vol $35.01 each |
142,954 | |
| Filed 2021-02-12 10:22 Tx date 2021-02-08 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,613,750
+125,000 vol $36.91 each |
1,527,176 | |
| Filed 2021-01-05 18:51 Tx date 2020-12-31 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+148,466 vol |
148,466 | |
| Filed 2021-01-05 18:50 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-01-05 18:38 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-01-05 18:35 Tx date 2020-12-31 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-148,466 vol |
5,000 | |
| Filed 2021-01-05 18:34 Tx date 2020-12-31 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+148,466 vol |
||
| Filed 2021-01-05 18:33 Tx date 2020-12-31 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-148,466 vol |
||
| Filed 2021-01-05 17:38 Tx date 2020-12-31 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+148,466 vol |
||
| Filed 2021-01-05 17:38 Tx date 2020-12-31 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+148,466 vol |
148,467 | |
| Filed 2021-01-05 17:36 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1 | ||
| Filed 2021-01-05 17:36 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Holder: Arvala Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-01-05 17:35 Tx date 2020-12-31 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-148,466 vol |
||
| Filed 2021-01-05 17:35 Tx date 2020-12-31 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-148,466 vol |
5,000 | |
| Filed 2020-07-02 19:48 Tx date 2020-06-23 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$100,000
+5,000 vol $20.00 each |
153,466 | |
| Filed 2020-07-02 19:47 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
148,466 | ||
| Filed 2020-07-02 19:46 Tx date 2020-06-22 |
$RPTX
Repare Therapeutics Inc. |
SEGAL, Lloyd M.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,402,176 | ||
| Filed 2018-07-05 Tx date 2018-06-29 |
$LEAF
MedReleaf Corp. |
SEGAL, Lloyd M.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit (DSU)
56 - Grant of rights
|
$180,017
+6,582 vol $27.35 each |
23,634 | |
| Filed 2017-06-13 Tx date 2017-06-07 |
$LEAF
MedReleaf Corp. |
SEGAL, Lloyd M.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit (DSU)
00 - Opening Balance-Initial SEDI Report
|
17,052 | ||
| Filed 2017-06-07 Tx date 2017-06-07 |
$LEAF
MedReleaf Corp. |
SEGAL, Lloyd M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$49,875
+5,250 vol $9.50 each |
5,250 | |
| Filed 2017-06-07 Tx date 2017-06-07 |
$LEAF
MedReleaf Corp. |
SEGAL, Lloyd M.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-07 Tx date 2017-06-07 |
$LEAF
MedReleaf Corp. |
SEGAL, Lloyd M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|